StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)

Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –

Liquidia cash

Cash and short-term investments held at the end of each period.

Liquidia's cash was $284.18M at Jun 30, 2026. For fiscal 2025 it was $190.68M, up 8.0% from the year before. The highest annual figure on record is $190.68M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$190.68M+8.0%
FY2024Dec 31, 2024$176.48M+110.9%
FY2023Dec 31, 2023$83.68M-10.3%
FY2022Dec 31, 2022$93.28M+62.2%
FY2021Dec 31, 2021$57.49M-12.0%
FY2020Dec 31, 2020$65.32M+17.1%
FY2019Dec 31, 2019$55.80M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$284.18M+63.9%
Q1 FY2026Mar 31, 2026$222.79M+31.2%
Q4 FY2025Dec 31, 2025$190.68M+8.0%
Q3 FY2025Sep 30, 2025$157.50M-22.9%
Q2 FY2025Jun 30, 2025$173.42M+30.3%
Q1 FY2025Mar 31, 2025$169.76M+7.5%
Q4 FY2024Dec 31, 2024$176.48M+110.9%
Q3 FY2024Sep 30, 2024$204.37M+168.1%
Q2 FY2024Jun 30, 2024$133.09M+50.9%
Q1 FY2024Mar 31, 2024$157.86M+67.2%
Q4 FY2023Dec 31, 2023$83.68M-10.3%
Q3 FY2023Sep 30, 2023$76.23M-22.5%
Q2 FY2023Jun 30, 2023$88.20M-15.1%
Q1 FY2023Mar 31, 2023$94.41M+63.4%
Q4 FY2022Dec 31, 2022$93.28M+62.2%
Q3 FY2022Sep 30, 2022$98.32M+53.5%
Q2 FY2022Jun 30, 2022$103.84M+53.0%
Q1 FY2022Mar 31, 2022$57.79M+7.7%
Q4 FY2021Dec 31, 2021$57.49M-12.0%
Q3 FY2021Sep 30, 2021$64.05M+14.8%
Q2 FY2021Jun 30, 2021$67.89M–
Q1 FY2021Mar 31, 2021$53.64M–
Q4 FY2020Dec 31, 2020$65.32M–
Q4 FY2019Dec 31, 2019$55.80M–

More Liquidia figures

See a number that looks wrong?